Format

Send to

Choose Destination
Am J Hematol. 2019 Apr;94(4):E117-E116. doi: 10.1002/ajh.25411. Epub 2019 Feb 4.

Eligibility for CAR T-cell therapy: An analysis of selection criteria and survival outcomes in chemorefractory DLBCL.

Author information

1
Department of Medicine, Division of Medical Oncology, University of Washington Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, DC.
2
CHI Franciscan Health, Franciscan Inpatient Services, Federal Way, Washington, DC.
3
Department of Radiation Oncology, University of Washington Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, DC.
PMID:
30663774
DOI:
10.1002/ajh.25411

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center